Catalyst Wire Dossier Catalyst Wire Dossier

Split, Cell-Based, Inactivated, Trivalent Influenza Vaccine

· Sanofi
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Split, Cell-Based, Inactivated, Trivalent Influenza Vaccine, covering 2012-12-17 to 2012-12-17. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity of a Split, Cell-Based, Inactivated, Trivalent Influenza Vaccine in Healthy Adult Subjects [Phase 2]

See pricing